Press Releases

Institute for OneWorld Health Highlights Need for New Chagas Disease Treatments in BBC TV Series

San Francisco, CA - January 25, 2005

BBC TV airs a 25-minute program on Chagas disease and treatment efforts, including a compound donated by a biotechnology company to OneWorld Health, the first nonprofit pharmaceutical company in the U.S. Chagas is a parasitic disease of the Americas that most commonly affects the heart. OneWorld Health develops new, affordable medicines for infectious diseases that disproportionately affect people in the developing world. The program is part of a new BBC TV “Kill or Cure” series that cover 10 diseases globally, focusing on the patients, the scientists and doctors developing new drugs and ways of preventing infection.

WHO

Discussions of drug development progress in Chagas disease feature Victoria Hale, Ph.D., CEO and Founder of OneWorld Health; James McKerrow, M.D., Ph.D., Professor, Departments of Pathology, Medicine and Pharmaceutical Chemistry, University of California at San Francisco; and James T. Palmer, Ph.D., Senior Director of Medicinal Chemistry, Celera Genomics, South San Francisco, whose company donated a compound as a potential treatment.

WHEN

22:30 (GMT) Thursday, 27 January

02:30 (GMT) Friday, 28 January

09:30 (GMT) Friday

17:30 (GMT) Friday

03:30 (GMT) Sunday, 30 January

Check local times for the “Kill or Cure” TV series at the BBC World website .



WHERE

Worldwide except the United States

RSS Feed